Cristina has more than 20 years of experience as a global strategist and corporate development executive. Her career has extended across Europe, North America, and Latin America where she has directed over twenty mergers and acquisitions projects with a focus in pharmaceuticals, biotech, aesthetic dermatology and consumer healthcare. Cristina’s vast experience includes corporate strategy, equity financing, high margin product innovation, global branding and strategic alliance building.
Cristina joined Or-Genix from Cantabria Labs, Madrid, Spain where, for the past 15 years, she was the Managing Director of Corporate Development. Over the course of her career she has been a valued participant and advisor to global and Fortune 500 firms, corporate boards, and venture capital. Earlier in her career, Cristina consulted for Pfizer, Microsoft, Telfonica, Repsol, Unilever, Santander, BUPA, Ericsson and Enresa.
Cristina received her BA from the University of Wisconsin, her MA from St. John’s College, Maryland and her MBA in Global Strategic Management from Macquarie Graduate School Management, NSW, Australia. She received advanced training at the Wharton School of Business and Harvard Business School. Besides her native tongue, English, she is fluent in Spanish and Portuguese.